Related Experiment Video
Updated: Dec 5, 2025

Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Surgical Revascularization With Cardiopulmonary Bypass on a Patient With Severe COVID-19
Olivier Montandrau1, Hannan Arana1, Franck Ehooman1
1Institut Mutualiste Montsouris, Paris, France.
Insights
This case study highlights a diabetic patient with COVID-19 who experienced heparin resistance during cardiac surgery. Effective management requires multidisciplinary collaboration and careful perioperative care, especially concerning ventilation and anticoagulation.
Area of Science:
- Cardiology
- Infectious Diseases
- Anesthesiology
Background:
- Coronavirus disease 2019 (COVID-19) can cause severe respiratory and prothrombotic complications.
- Cardiac surgery with cardiopulmonary bypass (CPB) activates hemostasis and inflammation.
- The interaction between COVID-19 and CPB in cardiac surgery is not well understood.
Observation:
- A diabetic patient with COVID-19 and three-vessel disease required urgent surgical revascularization.
- The patient exhibited significant heparin resistance during CPB.
- This resistance complicated the management of anticoagulation during the procedure.
Findings:
- COVID-19 may significantly alter the response to anticoagulation during CPB.
- Heparin resistance in COVID-19 patients undergoing cardiac surgery is a critical concern.
- Successful management necessitates a tailored approach to anticoagulation and ventilation.
Implications:
- Emphasizes the need for multidisciplinary team (MDT) discussion for complex cases.
- Highlights the importance of thorough preoperative assessment in COVID-19 patients.
- Stresses the critical role of meticulous perioperative management, including anticoagulation and mechanical ventilation, for patient safety.
Abstract:
The coronavirus disease 2019 (COVID-19) may lead to an acute respiratory distress syndrome by an inappropriate cytokine response and may predispose to a prothrombotic state through multiple pathways. Both can complicate the management of cardiac surgery with cardiopulmonary bypass, which is known to activate the hemostatic system and to exacerbate systemic inflammatory response. Little is known about the impact of cardiac surgery with cardiopulmonary bypass on viral pneumonia, particularly with the new coronavirus. In this article, we describe the case of a diabetic patient with COVID-19 and a concomitant 3-vessel disease with a formal indication for surgical revascularization, who unexpectedly presented with a high heparin resistance during cardiopulmonary bypass. Emphasis is placed on the importance of multidisciplinary team discussions before surgery, on the thorough preoperative assessment, and on the perioperative management, particularly regarding mechanical ventilation and anticoagulation.
Related Concept Videos
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiopulmonary Resuscitation II: ACLS Airway Management
Cardiomyopathy V: Interprofessional Care
Acute Coronary Syndrome IV: Interprofessional Care
Cardiopulmonary Resuscitation V: Advanced Airway Management Techniques

